TheraRadar

Nutricia

Pre-Approval PRO BETA

Also known as: Nutricia Research, Nutricia UK Ltd

🟡

Slowing Activity

No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 1/23/2025

7
Total Trials
4
Phase 3
2
Phase 2
0
Recruiting
79
Score

Pipeline by Phase

Phase 3
4
Phase 2
2
Phase 1
1

Therapeutic Focus

Growth Immunity Glycemic Response Subjects in Need of a Human Milk Fortifier (HMF) Tolerance

Clinical Trials (7)

NCT03062995 Phase 3 WITHDRAWN

A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on the Development of Allergic Manifestations in Infants at High Risk of Developing Allergy

Started: 6/1/2019

NCT03067714 Phase 3 COMPLETED

A Clinical Study to Investigate the Effect of a Partially Hydrolysed Infant Formula With Added Synbiotics on Gut Microbiota Composition and Clinical Effectiveness in Infants at High Risk of Developing Allergy

Started: 3/30/2017

NCT00688649 Phase 3 COMPLETED

Nutritional Supplement Compliance Study

Started: 5/1/2008

NCT03315221 Phase 2 COMPLETED

Renoir: A Randomised, Double-blind, Controlled Trial to Evaluate the Effects of a New Human Milk Fortifier on Growth and Tolerance in Preterm Infants.

Started: 3/8/2018

NCT03062761 Phase 2 COMPLETED

A Clinical Study to Investigate the Effects of an Infant Formula Containing Partially Hydrolysed Proteins on Growth, Safety and Tolerance in Healthy Term Infants

Started: 4/27/2017

NCT02013466 Phase 1 COMPLETED

Amino Acid Bioavailability in Healthy Elderly After Intake of an Oral Nutritional Supplement

Started: 10/1/2008

NCT06797349 Phase 4 COMPLETED

Glin4: Assessment of the Glycemic Responses to Nutritional Products

Started: 1/23/2025

Activity Status: Slowing
Last Trial Started: 1/23/2025
Last Trial Ended: 3/4/2025
Trials (12 months): 0
Completed Trials: 6
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.